SCM
Sio Capital Management Portfolio holdings
AUM
$249M
1-Year Return
117.71%
This Quarter Return
+13.59%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$328M
AUM Growth
+$67.2M
(+26%)
Cap. Flow
+$44.1M
Cap. Flow
% of AUM
13.47%
Top 10 Holdings %
Top 10 Hldgs %
41.01%
Holding
89
New
15
Increased
27
Reduced
12
Closed
21
Top Buys
| 1 |
Biogen
BIIB
|
$18.6M |
| 2 |
CVS Health
CVS
|
$12M |
| 3 |
GSK
GSK
|
$10.9M |
| 4 |
Ascendis Pharma
ASND
|
$10.6M |
| 5 |
Globus Medical
GMED
|
$10M |
Top Sells
| 1 |
Cencora
COR
|
$9.97M |
| 2 |
Cigna
CI
|
$9.92M |
| 3 |
Cardinal Health
CAH
|
$9.32M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.05M |
| 5 |
CELG
Celgene Corp
CELG
|
$6.56M |
Sector Composition
| 1 | Healthcare | 90.58% |
| 2 | Industrials | 1.25% |
| 3 | Technology | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bionano Genomics
BNGO
$17M
| $4.63M | 1.25% |
2,564
+170
| +7% | +$307K |
|
27
Sutro Biopharma
STRO
$86.5M
| $4.54M | 1.23% |
398,796
+116,882
| +41% | +$1.33M |
|
28
Smith & Nephew
SNN
$16.4B
| $4.43M | 1.19% |
110,327
+8,164
| +8% | +$327K |
|
|
EGRX
29
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.28M | 1.15% |
+84,695
| New | +$4.28M |
|
|
SYNH
30
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.24M | 1.14% |
+81,899
| New | +$4.24M |
|
|
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.16M | 1.12% |
+56,800
| New | +$4.16M |
|
32
Rigel Pharmaceuticals
RIGL
$720M
| $4.14M | 1.12% |
160,927
-57,128
| -26% | -$1.47M |
|
|
SRCL
33
DELISTED
Stericycle Inc
SRCL
| $4.08M | 1.1% |
+75,000
| New | +$4.08M |
|
34
PetMed Express
PETS
$62.8M
| $4.06M | 1.1% |
+178,151
| New | +$4.06M |
|
|
RVNC
35
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.01M | 1.08% |
254,581
+86,857
| +52% | +$1.37M |
|
36
United Therapeutics
UTHR
$17.2B
| $3.95M | 1.07% |
33,655
+3,655
| +12% | +$429K |
|
37
Zimmer Biomet
ZBH
$20.8B
| $3.83M | 1.03% |
30,900
-5,298
| -15% | -$657K |
|
38
UnitedHealth
UNH
$281B
| $3.81M | 1.03% |
15,407
+1,200
| +8% | +$297K |
|
39
Gyre Therapeutics
GYRE
$688M
| $3.68M | 0.99% |
60,574
+21,691
| +56% | +$1.32M |
|
|
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
| $3.19M | 0.86% |
239,827
+52,500
| +28% | +$697K |
|
41
Icon
ICLR
$13.7B
| $3.07M | 0.83% |
22,471
+905
| +4% | +$124K |
|
42
Humana
HUM
$37.5B
| $2.88M | 0.78% |
10,817
-5,500
| -34% | -$1.46M |
|
43
Harrow
HROW
$1.34B
| $2.7M | 0.73% |
541,114
+205,750
| +61% | +$1.02M |
|
|
GNFT
44
Genfit
GNFT
$194M
| $2.22M | 0.6% |
+92,637
| New | +$2.22M |
|
|
UROV
45
DELISTED
Urovant Sciences Ltd.
UROV
| $2.16M | 0.58% |
215,042
-592,818
| -73% | -$5.96M |
|
|
FRTX
46
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.94M | 0.52% |
5,130
| – | – |
|
|
LOGC
47
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $1.57M | 0.42% |
158,958
| – | – |
|
48
Inogen
INGN
$220M
| $1.45M | 0.39% |
15,189
+2,365
| +18% | +$226K |
|
49
Achieve Life Sciences
ACHV
$143M
| $1.36M | 0.37% |
21,074
-8,795
| -29% | -$568K |
|
50
Senseonics Holdings
SENS
$365M
| $1.36M | 0.37% |
554,858
+75,000
| +16% | +$184K |
|